Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer
Clinical trial NCT03204734 · UNKNOWN
Trial details
- NCT number
- NCT03204734
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2020-12-30
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.